Organogenesis Holdings, Inc. (ORGO)
3.74
-0.02
(-0.53%)
USD |
NASDAQ |
Feb 12, 16:00
3.79
+0.05
(+1.34%)
After-Hours: 20:00
Organogenesis Holdings Free Cash Flow : -51.65M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Integra LifeSciences Holdings Corp. | -14.47M |
| Celularity, Inc. | -8.113M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Savara, Inc. | -99.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.079M |
| Cash from Investing (Quarterly) | -2.235M |
| Cash from Financing (Quarterly) | -10.21M |
| Free Cash Flow Per Share (Quarterly) | 0.0065 |
| Free Cash Flow to Equity (Quarterly) | 0.85M |
| Free Cash Flow to Firm (Quarterly) | 0.844M |
| Free Cash Flow Yield | -10.70% |